Lorajmine

This classification denotes an anti-arrhythmia agent with the molecular formula C22H27ClN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) F96VX65849, chemically known as ajmalan-17,21-diol, 17-(chloroacetate) but more generally known as lorajmine, which bears US NIH Compound Identifier 92090. European Medicines Agency schedules Lorajmine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08579MIG. World Health Organization schedules lorajmine in its Anatomical Therapeutic Chemical (ATC) Classification. LORAJMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule lorajmine under HS 29399900 and SITC 54149. As of Q4 2014, LORAJMINE remains US FDA's Preferred Term for this commodity. SMILES: CLCOC(=O)C1C23C(N(C4C3CCCC4)C)C3N4C(C1C(C3)C(C4O)CC)C2.